Is Elevance Health Stock a Good Investment?
Elevance Health Investment Advice | ELV |
- Examine Elevance Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Elevance Health's leadership team and their track record. Good management can help Elevance Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Elevance Health's business and its evolving consumer preferences.
- Compare Elevance Health's performance and market position to its competitors. Analyze how Elevance Health is positioned in terms of product offerings, innovation, and market share.
- Check if Elevance Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Elevance Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Elevance Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Elevance Health is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Elevance Health Stock
Researching Elevance Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Elevance Health was currently reported as 181.62. The company has Price/Earnings To Growth (PEG) ratio of 0.93. Elevance Health recorded earning per share (EPS) of 25.67. The entity last dividend was issued on the 10th of March 2025. The firm had 2:1 split on the 1st of June 2005.
To determine if Elevance Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elevance Health's research are outlined below:
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Lowe Brockenbrough Co. Inc. Sells 2,966 Shares of Elevance Health, Inc. |
Elevance Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elevance Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elevance Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 17th of April 2024 Upcoming Quarterly Report | View | |
| 17th of July 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 22nd of January 2025 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 31st of December 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Elevance Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Elevance Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2002-04-29 | 2002-03-31 | 0.42 | 0.47 | 0.05 | 11 | ||
2004-04-28 | 2004-03-31 | 0.73 | 0.81 | 0.08 | 10 | ||
2008-04-23 | 2008-03-31 | 1.19 | 1.07 | -0.12 | 10 | ||
2012-01-25 | 2011-12-31 | 1.12 | 0.99 | -0.13 | 11 | ||
2010-01-27 | 2009-12-31 | 1.02 | 1.16 | 0.14 | 13 | ||
2010-11-03 | 2010-09-30 | 1.58 | 1.74 | 0.16 | 10 | ||
2019-01-30 | 2018-12-31 | 2.2 | 2.44 | 0.24 | 10 | ||
2012-11-07 | 2012-09-30 | 1.84 | 2.09 | 0.25 | 13 |
Know Elevance Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Elevance Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elevance Health backward and forwards among themselves. Elevance Health's institutional investor refers to the entity that pools money to purchase Elevance Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.9 M | Massachusetts Financial Services Company | 2024-12-31 | 2.5 M | Baillie Gifford & Co Limited. | 2024-12-31 | 2.5 M | Northern Trust Corp | 2024-12-31 | 2.4 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 2.4 M | Fmr Inc | 2024-12-31 | 2.2 M | Orbis Allan Gray Ltd | 2024-12-31 | 2.2 M | Alliancebernstein L.p. | 2024-12-31 | 2.1 M | Amvescap Plc. | 2024-12-31 | 2.1 M | Vanguard Group Inc | 2024-12-31 | 21.5 M | Blackrock Inc | 2024-12-31 | 20.4 M |
Elevance Health's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 97.12 B.Market Cap |
|
Elevance Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.06 | |
| Return On Capital Employed | 1.51 | 1.59 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.14 | 0.10 |
Determining Elevance Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Elevance Health is a good buy. For example, gross profit margin measures Elevance Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elevance Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Elevance Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Elevance Health. Check Elevance Health's Beneish M Score to see the likelihood of Elevance Health's management manipulating its earnings.
Evaluate Elevance Health's management efficiency
Elevance Health has Return on Asset of 0.0509 % which means that on every $100 spent on assets, it made $0.0509 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1477 %, implying that it generated $0.1477 on every 100 dollars invested. Elevance Health's management efficiency ratios could be used to measure how well Elevance Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 1.59 in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025. At this time, Elevance Health's Other Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 52.6 B in 2025, whereas Intangible Assets are likely to drop slightly above 8.5 B in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 178.79 | 187.73 | |
| Tangible Book Value Per Share | 4.55 | 3.93 | |
| Enterprise Value Over EBITDA | 11.93 | 7.91 | |
| Price Book Value Ratio | 2.07 | 1.51 | |
| Enterprise Value Multiple | 11.93 | 7.91 | |
| Price Fair Value | 2.07 | 1.51 | |
| Enterprise Value | 115.7 B | 121.4 B |
The decision-making processes within Elevance Health are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Basic technical analysis of Elevance Stock
As of the 23rd of March, Elevance Health shows the Mean Deviation of 1.23, downside deviation of 1.49, and Coefficient Of Variation of 833.15. Elevance Health technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Elevance Health variance, as well as the relationship between the value at risk and skewness to decide if Elevance Health is priced favorably, providing market reflects its regular price of 427.19 per share. Given that Elevance Health has jensen alpha of 0.2109, we urge you to verify Elevance Health's prevailing market performance to make sure the company can sustain itself at a future point.Elevance Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevance Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevance Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevance Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ronald Penczek over three months ago Disposition of 1055 shares by Ronald Penczek of Elevance Health at 475.17 subject to Rule 16b-3 | ||
Blair Todt over three months ago Disposition of 7 shares by Blair Todt of Elevance Health at 480.49 subject to Rule 16b-3 | ||
Peru Ramiro G over six months ago Disposition of 753 shares by Peru Ramiro G of Elevance Health at 531.52 subject to Rule 16b-3 | ||
Neri Antonio F over six months ago Acquisition by Neri Antonio F of 388 shares of Elevance Health subject to Rule 16b-3 | ||
Ronald Penczek over six months ago Disposition of tradable shares by Ronald Penczek of Elevance Health at 454.35 subject to Rule 16b-3 | ||
Schneider Ryan M. over six months ago Acquisition by Schneider Ryan M. of 457 shares of Elevance Health subject to Rule 16b-3 | ||
Charles Kendrick over six months ago Acquisition by Charles Kendrick of 7786 shares of Elevance Health at 469.03 subject to Rule 16b-3 | ||
Zielinski Thomas C over a year ago Sale by Zielinski Thomas C of 5254 shares of Elevance Health |
Elevance Health's Outstanding Corporate Bonds
Elevance Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Elevance Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Elevance bonds can be classified according to their maturity, which is the date when Elevance Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US03674XAS53 Corp BondUS03674XAS53 | View | |
| US03674XAQ97 Corp BondUS03674XAQ97 | View | |
| ANTHEM INC Corp BondUS036752AN31 | View | |
| ANTHEM INC Corp BondUS036752AM57 | View | |
| ANTHEM INC Corp BondUS036752AL74 | View | |
| ELV 41 15 MAY 32 Corp BondUS036752AT01 | View | |
| ANTHEM INC Corp BondUS036752AS28 | View | |
| ANTHEM INC Corp BondUS036752AR45 | View |
Understand Elevance Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Elevance Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1109 | |||
| Market Risk Adjusted Performance | 0.4113 | |||
| Mean Deviation | 1.23 | |||
| Semi Deviation | 1.25 | |||
| Downside Deviation | 1.49 | |||
| Coefficient Of Variation | 833.15 | |||
| Standard Deviation | 1.59 | |||
| Variance | 2.52 | |||
| Information Ratio | 0.1561 | |||
| Jensen Alpha | 0.2109 | |||
| Total Risk Alpha | 0.3012 | |||
| Sortino Ratio | 0.1668 | |||
| Treynor Ratio | 0.4013 | |||
| Maximum Drawdown | 8.26 | |||
| Value At Risk | (2.13) | |||
| Potential Upside | 2.72 | |||
| Downside Variance | 2.21 | |||
| Semi Variance | 1.57 | |||
| Expected Short fall | (1.29) | |||
| Skewness | 0.2062 | |||
| Kurtosis | 0.3465 |
| Risk Adjusted Performance | 0.1109 | |||
| Market Risk Adjusted Performance | 0.4113 | |||
| Mean Deviation | 1.23 | |||
| Semi Deviation | 1.25 | |||
| Downside Deviation | 1.49 | |||
| Coefficient Of Variation | 833.15 | |||
| Standard Deviation | 1.59 | |||
| Variance | 2.52 | |||
| Information Ratio | 0.1561 | |||
| Jensen Alpha | 0.2109 | |||
| Total Risk Alpha | 0.3012 | |||
| Sortino Ratio | 0.1668 | |||
| Treynor Ratio | 0.4013 | |||
| Maximum Drawdown | 8.26 | |||
| Value At Risk | (2.13) | |||
| Potential Upside | 2.72 | |||
| Downside Variance | 2.21 | |||
| Semi Variance | 1.57 | |||
| Expected Short fall | (1.29) | |||
| Skewness | 0.2062 | |||
| Kurtosis | 0.3465 |
Consider Elevance Health's intraday indicators
Elevance Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Elevance Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Elevance Health Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 10th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 20th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Elevance Stock media impact
Far too much social signal, news, headlines, and media speculation about Elevance Health that are available to investors today. That information is available publicly through Elevance media outlets and privately through word of mouth or via Elevance internal channels. However, regardless of the origin, that massive amount of Elevance data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Elevance Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Elevance Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Elevance Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Elevance Health alpha.
Elevance Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Elevance Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Elevance Health Historical Investor Sentiment
Investor biases related to Elevance Health's public news can be used to forecast risks associated with an investment in Elevance. The trend in average sentiment can be used to explain how an investor holding Elevance can time the market purely based on public headlines and social activities around Elevance Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Elevance Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Elevance Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Elevance Health news discussions. The higher the estimate score, the more favorable the investor's outlook on Elevance Health.
Elevance Health Maximum Pain Price Across June 20th 2025 Option Contracts
Elevance Health's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Elevance Health close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Elevance Health's options.
Elevance Health Corporate Management
| Chris Rigg | SVP Division | Profile | |
| Ronald Penczek | Controller VP | Profile | |
| Scott Anglin | Treasurer SVP | Profile | |
| John Gallina | Ex CFO | Profile | |
| Julie Goon | Senior Affairs | Profile | |
| Felicia Norwood | Executive Benefits | Profile | |
| Charles Kendrick | Executive Benefits | Profile |
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.